On September 24, Guangzhou KingMed Cold chain Logistics., LTD. (hereinafter referred to as the "KingMed Cold chain Logistics") passed the 《medical test biological sample cold chain logistics operation specification》 (GB / T42186-2022) national standard enterprise review, marks the KingMed Cold chain Logistics in medical inspection biological samples cold chain logistics operation of professional strength and management level have reached the national standard.

The review team was organized by the Medical Device Supply Chain Branch of China Federation of Logistics and Purchasing and conducted a comprehensive and strict inspection on the cold chain logistics management, quality management, risk management and logistics operation of KingMed Cold chain Logistics. With its profound accumulation and excellent performance in its field, KingMed Cold chain Logistics successfully passed the review and became the first batch of enterprises to meet the standard since the implementation of the standard.

Review site

As a wholly-owned subsidiary of KingMed, Kingfield Medical focuses on providing safe, professional and efficient cold chain logistics services for customers in the fields of life science, medical laboratory, health testing, biomedicine and other fields. The company has a logistics team with more than 20 years of experience, adopts the modern information management mode, and realizes the whole life process monitoring of goods through the combination of GPS positioning and accurate temperature control, to ensure the safety and timeliness of cold chain logistics. The review further demonstrates the professional strength and service level of KingMed Cold chain Logistics in the field of cold chain logistics.

Review site

It is worth noting that the passing of the review is not alone. On the same day, Guangzhou KingMed also successfully passed the standard enterprise evaluation of the national standard of 《Medical Laboratory Biological sample Cold Chain Logistics Operation Standard》. Before that, several subsidiaries of KingMed, including Zhengzhou KingMed and Qingdao KingMed, have passed the review. So far, all the 16 subsidiaries of KingMed Medical participating in the pilot have completed the evaluation of the standard enterprises and achieved the overall standard. This achievement represents that KingMed Medical attaches great importance to the leading role of KingMed Cold chain Logistics and its other subsidiaries in continuously promoting the development of the medical cold chain industry and improving the overall management level, and sets a new benchmark for the healthy development of the medical cold chain logistics market segment.

In the future, KingMed Cold chain Logistics will continue to uphold the principles of high standards and strict requirements, constantly optimize the medical cold chain logistics management system, strengthen technological innovation and talent training, and contribute more to ensure the quality of cold chain logistics and improve the safety of biomedicine and life science. At the same time, the company will also actively promote the use of national standards, promote the healthy development of the medical cold chain logistics industry, and work with industry partners to build a safer, more efficient and standardized medical cold chain logistics ecosystem.